Method: 40 workers with known history of OA enrolled in this study.Twice daily inhalation therapy with Fluticasone propionate ( 500 mcg ) and Salmeterol ( 50 mcg ) was initiated. At the enrollment and every 3 months, PFT and respiratory symptom score (RSS) were checked for one year period. Need for emergency use of salbutamol also was recorded .
Results: Mean baseline FEV1 was 80% of predicted values, but no statistically significant differences in FEV1 and RSS were seen compare to baseline values after one year treatment.
Conclusion : Regular use ofcombination therapy with inhaled corticosteroids and long-acting bronchodilators can prevent respiratory symptoms deterioration over one year period in petrochemistry workers with occupational asthma and persistant exposure in work place.